Zobrazeno 1 - 10 of 35 pro vyhledávání: '"Suzana M. Lobo"'
1
Akademický článek
Impact of perioperative hemodynamic optimization therapies in surgical patients: economic study and meta-analysis
Autor: João M. Silva-Jr, Pedro Ferro L. Menezes, Suzana M. Lobo, Flávia Helena S. de Carvalho, Mariana Augusta N. de Oliveira, Francisco Nilson F. Cardoso Filho, Bruna N. Fernando, Maria Jose C. Carmona, Vanessa D. Teich, Luiz Marcelo S. Malbouisson
Publikováno v: BMC Anesthesiology, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Several studies suggest that hemodynamic optimization therapies can reduce complications, the length of hospital stay and costs. However, Brazilian data are scarce. Therefore, the objective of this analysis was to evaluate whether
Externí odkaz: https://doaj.org/article/5f87316447f348859acdc855dd43ae14
Zobrazit plný text záznamu
3
Akademický článek
Fatal scorpion envenomation: a case report
Autor: Suzana M. Lobo, Flavio E. Nacul, Manuela Francisco Balthazar Neves, Carlos Alberto Caldeira Mendes
Publikováno v: Anaesthesiology Intensive Therapy, Vol 51, Iss 2, Pp 163-165 (2019)
Externí odkaz: https://doaj.org/article/796a41dfedd44251a3d4c3feb90757c0
Zobrazit plný text záznamu
4
Surging ICU during COVID-19 pandemic: an overview
Autor: Yaseen M, Arabi, Sheila Nainan, Myatra, Suzana M, Lobo
Publikováno v: Current Opinion in Critical Care. 28:638-644
The coronavirus disease 2019 (COVID-19) pandemic has posed great challenges to intensive care units (ICUs) across the globe. The objective of this review is to provide an overview on how ICU surging was managed during COVID-19 pandemic, with a specia
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c9c0a71f0273b78c284a970e49459ff
https://doi.org/10.1097/mcc.0000000000001001
Zobrazit plný text záznamu
6
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Autor: Alexander P J Vlaar, Martin Witzenrath, Pieter van Paassen, Leo M A Heunks, Bruno Mourvillier, Sanne de Bruin, Endry H T Lim, Matthijs C Brouwer, Pieter R Tuinman, José F K Saraiva, Gernot Marx, Suzana M Lobo, Rodrigo Boldo, Jesus A Simon-Campos, Alexander D Cornet, Anastasia Grebenyuk, Johannes M Engelbrecht, Murimisi Mukansi, Philippe G Jorens, Robert Zerbib, Simon Rückinger, Korinna Pilz, Renfeng Guo, Diederik van de Beek, Niels C Riedemann, Alexander P.J. Vlaar, Leo M.A. Heunks, Endry H.T. Lim, Matthijs C. Brouwer, Pieter R. Tuinman, José Francisco K. Saraiva, Suzana Lobo, Jesus Simon-Campos, Alexander D. Cornet, Johannes Engelbrecht, Philippe G. Jorens, Niels C. Riedemann, Pierre Bulpa, Fabio S. Taccone, Greet Hermans, Marc Diltoer, Michael Piagnerelli, Nikolaas De Neve, Antonio T. Freire, Felipe D. Pizzol, Anna Karolina Marinho, Victor H. Sato, Clovis Arns da Cunha, Mathilde Neuville, Jean Dellamonica, Djillali Annane, Antoine Roquilly, Jean Luc Diehl, Francis Schneider, Jean Paul Mira, Jean Baptiste Lascarrou, Luc Desmedt, Claire Dupuis, Carole Schwebel, Guillaume Thiéry, Matthias Gründling, Marc Berger, Tobias Welte, Michael Bauer, Ulrich Jaschinski, Klaus Matschke, Roberto Mercado-Longoria, Belinda Gomez Quintana, Jorge Alberto Zamudio-Lerma, Juan Moreno Hoyos Abril, Angel Aleman Marquez, Peter Pickkers, Luuk Otterspoor, Luis Hercilla Vásquez, Carlos Rafael Seas Ramos, Alejandro Peña Villalobos, Gonzalo Gianella Malca, Victoria Chávez, Victor Filimonov, Vladimir Kulabukhov, Pinak Acharya, Sjoerd A.M.E.G. Timmermans, Matthias H. Busch, Floor L.F. van Baarle, Rutger Koning, Liora ter Horst, Nora Chekrouni, Thijs M. van Soest, Marleen A. Slim, Lonneke A. van Vught, Rombout B.E. van Amstel, Sabine E. Olie, Ingeborg E. van Zeggeren, Marcel C.G. van de Poll, Claus Thielert, Dorothee Neukirchen
Publikováno v: The Lancet Respiratory medicine, 10(12), 1137-1146. ELSEVIER SCI LTD
Lancet respiratory medicine, 10(12), 1137-1146. Elsevier Limited
Lancet Respiratory Medicine, 10, 12, pp. 1137-1146
The lancet respiratory medicine
PANAMO study group 2022, ' Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO) : a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial ', Lancet respiratory medicine, vol. 10, no. 12, pp. 1137-1146 . https://doi.org/10.1016/S2213-2600(22)00297-1
lancet. Respiratory medicine, 10(12), 1137-1146. Elsevier Limited
Lancet Respiratory Medicine, 10, 1137-1146
Contains fulltext : 287661.pdf (Publisher’s version ) (Closed access) BACKGROUND: Vilobelimab, an anti-C5a monoclonal antibody, was shown to be safe in a phase 2 trial of invasively mechanically ventilated patients with COVID-19. Here, we aimed to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8ba6e900c408360d398f60555ae06e
https://cris.maastrichtuniversity.nl/en/publications/bd6096d8-38fc-4032-bed0-e61be7ec1575
Zobrazit plný text záznamu
8
Akademický článek
Polymorphisms IL10-819 and TLR-2 are potentially associated with sepsis in Brazilian patients
Autor: Fernanda Carregaro, Adriana Carta, José Antônio Cordeiro, Suzana M Lobo, Eloiza H Tajara da Silva, Andréia M Leopoldino
Publikováno v: Memorias do Instituto Oswaldo Cruz, Vol 105, Iss 5, Pp 649-656 (2010)
Genetic variation in immune response is probably involved in the progression of sepsis and mortality in septic patients. However, findings in the literature are sometimes conflicting or their significance is uncertain. Thus, we investigated the possi
Externí odkaz: https://doaj.org/article/f9dba520761f4230ba9cc44d35ec4d3a
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje